Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Petricciani

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Developments in Biological Standardization|January 1, 1986
Biologicals and vaccines: regulatory perspectivesJ C Petricciani
Developments in Biological Standardization|January 1, 1987
Should continuous cell lines be used as substrates for biological products?J C Petricciani
Developments in Biological Standardization|January 1, 2000
Cell substrates: lessons learned and challenges remainingJ C Petricciani
Lancet (London, England)|October 29, 2000
Recombinant DNA vaccines and therapeuticsJ C Petricciani
Developments in Biological Standardization|December 13, 1976
Nonhuman primate diploid cells for vaccine productionJ C Petricciani
Vaccine|January 1, 1993
Global immunization against AIDS: economic considerationsJ C Petricciani
Developments in Biological Standardization|January 1, 1992
Cell line issues: historical and future perspectivesJ C Petricciani
AIDS Research and Human Retroviruses|January 1, 1994
Global HIV vaccines: economic considerationsJ C Petricciani
Cytotechnology|November 13, 2008
An overview of viral and viral-like agents in cell culture systemsJ C Petricciani
Developments in Biological Standardization|January 1, 1985
Safety issues relating to the use of mammalian cells as hostsJ C Petricciani
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Developments in Biological Standardization|January 1, 1986
Biologicals and vaccines: regulatory perspectivesJ C Petricciani
Developments in Biological Standardization|January 1, 1987
Should continuous cell lines be used as substrates for biological products?J C Petricciani
Developments in Biological Standardization|January 1, 2000
Cell substrates: lessons learned and challenges remainingJ C Petricciani
Lancet (London, England)|October 29, 2000
Recombinant DNA vaccines and therapeuticsJ C Petricciani
Developments in Biological Standardization|December 13, 1976
Nonhuman primate diploid cells for vaccine productionJ C Petricciani
Vaccine|January 1, 1993
Global immunization against AIDS: economic considerationsJ C Petricciani
Developments in Biological Standardization|January 1, 1992
Cell line issues: historical and future perspectivesJ C Petricciani
AIDS Research and Human Retroviruses|January 1, 1994
Global HIV vaccines: economic considerationsJ C Petricciani
Cytotechnology|November 13, 2008
An overview of viral and viral-like agents in cell culture systemsJ C Petricciani
Developments in Biological Standardization|January 1, 1985
Safety issues relating to the use of mammalian cells as hostsJ C Petricciani
Pageof 10